Learn more

STEMMEDIENCE CO LTD

Overview
  • Total Patents
    15
About

STEMMEDIENCE CO LTD has a total of 15 patent applications. Its first patent ever was published in 2008. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are GHO ST HOLDING B V, TIARA STEM CELL INST and GENEVRIER SA LAB.

Patent filings in countries

World map showing STEMMEDIENCE CO LTDs patent filings in countries

Patent filings per year

Chart showing STEMMEDIENCE CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Yoon Byung Sun 14
#2 Jun Eun Kyoung 14
#3 You Seung Kwon 11
#4 Lee Jang Ho 9
#5 Lee Jong Won 9
#6 Cho Kyoung Shik 9
#7 Lee Jung Han 9
#8 Lee Hwang Heui 9
#9 Moon Jai Hee 8
#10 Jung Hye Youn 8

Latest patents

Publication Filing date Title
KR20130008293A Large scale production of growth promoting factors using fetus-derived mesenchymal stem cells from amniotic fluids with hypoxic condition and composition for regenerating skin using the same
KR20130003159A Method for manufacturing fetus-derived mesenchymal stem cells from amniotic fluids using selenium containing medium
KR20130003715A Method for manufacturing culture solution of fetus-derived mesenchymal stem cells from amniotic fluids using shear stress
KR20090126227A A method for preparing blood vessel stem cells from women labia minora skin cells by reprogramming method, and use of reprogrammed blood vessel endothelial cells as a cell therapy product
KR20090126226A A method for preparing endodermal precursor cells and insulin secretion cells from women labia minora skin cell by reprogramming method, and use of reprogrammed insulin secretion cells as a cell therapy product
KR20100105167A Compositions for promoting hair growth using fetus-derived mesenchymal stem cells from amniotic fluids
KR20100105166A Compositions for improving skin conditions using fetus-derived mesenchymal stem cells from amniotic fluids
KR20100105165A Large scale production of growth promoting factors using fetus-derived mesenchymal stem cells from amniotic fluids
KR20090100901A A method for preparing blood vessel stem cells from women labia minora skin cells by reprogramming method, and use of reprogrammed blood vessel endothelial cells as a cell therapy product
KR20090100900A A method for preparing multipotent neural stem cells from women labia minora skin cells by reprogramming method, and use of reprogrammed neural stem cells as a cell therapy product
KR20090100899A A method for preparing endodermal precursor cells and insulin secretion cells from women labia minora skin cell by reprogramming method, and use of reprogrammed insulin secretion cells as a cell therapy product